Lindynette

Ethinylestradiol and Gestodene, the active ingredients in Lindynette, are a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus. The formulation combines a synthetic estrogen with a progestogen to provide reliable cycle control and reduce the risk of unintended conception.

GNH USA supplies Lindynette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our global distribution network ensures consistent quality and compliance with EU regulatory standards, enabling timely delivery to healthcare providers.

Lindynette, a combined oral contraceptive, is indicated for hormonal regulation related to contraception.

Pregnancy prevention: provides reliable contraception by suppressing ovulation and modifying cervical mucus. Menstrual cycle regulation: helps achieve more predictable bleeding patterns and reduces menstrual discomfort. Acne management: may improve acne associated with hormonal fluctuations in women. Endometriosis symptom relief: can reduce menstrual pain associated with endometriosis.

Common Side Effects: - Nausea: mild to moderate stomach upset, often transient. - Breast tenderness: discomfort or swelling of breast tissue. - Headache: occasional tension‑type or migraine‑like pain. - Weight gain: modest increase due to fluid retention. - Mood changes: irritability or emotional fluctuations. - Spotting: irregular bleeding between periods.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Arterial thrombosis: stroke or myocardial infarction. - Hypertension: new‑onset or worsening high blood pressure. - Liver tumor: benign hepatic adenoma. - Gallbladder disease: formation of gallstones. - Severe allergic reaction: anaphylaxis, rash, or angioedema.

Before prescribing Lindynette, clinicians should consider several safety factors.

Assess cardiovascular risk: evaluate history of thrombosis, smoking, hypertension before prescribing. Avoid use in pregnancy: discontinue if pregnancy is confirmed. Monitor blood pressure: check regularly during therapy. Review concomitant medications: consider potential interactions that may reduce efficacy. Advise smoking cessation: especially for women over 35 years of age. Store at ambient temperature: keep below 25 °C, protect from moisture and light.

Lindynette may interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Rifampicin, carbamazepine, phenytoin: strong enzyme inducers that markedly reduce contraceptive effectiveness. - St. John’s wort: herbal inducer that may decrease hormone levels and increase risk of breakthrough bleeding. - Protease inhibitors (e.g., ritonavir): may increase estrogen exposure and raise thrombotic risk.

Moderate Interactions (Monitor Closely): - SSRIs (e.g., fluoxetine): may increase bleeding tendency when combined with hormonal contraceptives. - Antihypertensives (e.g., ACE inhibitors): additive blood pressure lowering effect may require monitoring. - Diuretics (e.g., thiazides): may affect electrolyte balance and require periodic assessment.